14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today AKBA ranks #14434 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Akebia Therapeutics Stock Forecast NASDAQ:AKBA

$2.03 (-1.93%)

Volume: 3M

Closed: Jan 25, 2022

Hollow Logo Score: -4.017

Akebia Therapeutics Stock Forecast

$2.03 (-1.93%)

Volume: 3M

Closed: Jan 25, 2022

Score Hollow Logo -4.017

Akebia Therapeutics Stock Price (Quote) NASDAQ:AKBA

$2.03 ( -1.93% ) Tuesday, 25th Jan 2022

Range Low Price High Price Comment
30 days $1.85 $2.51 Tuesday, 25th Jan 2022 AKBA stock ended at $2.03. This is 1.93% less than the trading day before Monday, 24th Jan 2022. During the day the stock fluctuated 6.70% from a day low at $1.94 to a day high of $2.07.
90 days $1.85 $3.35
52 weeks $1.85 $5.14

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
2022-01-25 $1.95 $2.07 $1.94 $2.03 3 255 224
2022-01-24 $1.93 $2.07 $1.85 $2.07 5 057 071
2022-01-21 $2.02 $2.09 $1.99 $2.00 3 461 936
2022-01-20 $2.09 $2.20 $2.04 $2.04 2 514 065
2022-01-19 $2.09 $2.21 $2.08 $2.09 2 786 766
2022-01-18 $2.20 $2.20 $2.05 $2.05 3 029 343
2022-01-14 $2.12 $2.21 $2.04 $2.20 4 374 149
2022-01-13 $2.23 $2.31 $2.13 $2.13 3 468 899
2022-01-12 $2.29 $2.33 $2.20 $2.21 2 764 784
2022-01-11 $2.28 $2.37 $2.25 $2.29 1 956 047
2022-01-10 $2.19 $2.28 $2.16 $2.27 2 339 183
2022-01-07 $2.28 $2.32 $2.19 $2.21 2 400 995
2022-01-06 $2.26 $2.32 $2.20 $2.26 2 746 300
2022-01-05 $2.36 $2.43 $2.24 $2.24 2 804 169
2022-01-04 $2.47 $2.49 $2.31 $2.36 2 324 174
2022-01-03 $2.28 $2.48 $2.28 $2.45 2 476 870
2021-12-31 $2.29 $2.35 $2.24 $2.26 3 532 806
2021-12-30 $2.31 $2.40 $2.26 $2.29 2 181 736
2021-12-29 $2.29 $2.33 $2.22 $2.29 2 286 894
2021-12-28 $2.42 $2.47 $2.20 $2.28 6 216 505
2021-12-27 $2.50 $2.51 $2.39 $2.40 2 479 978
2021-12-23 $2.51 $2.57 $2.47 $2.53 1 629 985
2021-12-22 $2.50 $2.53 $2.43 $2.48 2 088 721
2021-12-21 $2.48 $2.54 $2.44 $2.49 3 046 283
2021-12-20 $2.39 $2.52 $2.35 $2.48 2 794 192
2021-12-17 $2.36 $2.57 $2.34 $2.45 16 356 786
2021-12-16 $2.49 $2.49 $2.33 $2.37 3 593 853
2021-12-15 $2.42 $2.45 $2.22 $2.45 5 898 920
2021-12-14 $2.50 $2.53 $2.36 $2.38 5 024 426
2021-12-13 $2.49 $2.58 $2.43 $2.55 3 521 053
2021-12-10 $2.59 $2.63 $2.48 $2.50 2 447 439
2021-12-09 $2.66 $2.72 $2.55 $2.55 2 327 414
2021-12-08 $2.72 $2.73 $2.63 $2.70 2 132 309
2021-12-07 $2.61 $2.75 $2.61 $2.71 3 264 355
2021-12-06 $2.52 $2.59 $2.43 $2.54 2 660 714
2021-12-03 $2.70 $2.70 $2.51 $2.52 3 484 573
2021-12-02 $2.56 $2.69 $2.52 $2.67 3 256 349
2021-12-01 $2.71 $2.72 $2.56 $2.57 3 305 004
2021-11-30 $2.60 $2.74 $2.57 $2.71 3 766 414
2021-11-29 $2.67 $2.74 $2.61 $2.62 2 565 780
2021-11-26 $2.75 $2.77 $2.63 $2.67 2 404 687
2021-11-24 $2.73 $2.82 $2.68 $2.79 2 172 172
2021-11-23 $2.67 $2.78 $2.61 $2.75 2 882 825
2021-11-22 $2.78 $2.78 $2.65 $2.66 2 602 305
2021-11-19 $2.76 $2.81 $2.72 $2.78 1 783 111
2021-11-18 $2.82 $2.84 $2.70 $2.76 2 641 892
2021-11-17 $2.85 $2.90 $2.76 $2.80 2 627 361
2021-11-16 $2.85 $2.88 $2.80 $2.84 2 484 202
2021-11-15 $2.89 $2.92 $2.84 $2.87 2 592 296
2021-11-12 $2.99 $2.99 $2.85 $2.87 1 916 628

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is vadadustat, an oral therapy which has completed a Phase II study for the treatment of anemia related to chronic kidney disease in both non-dialysis and dialysis patients; and clinical product candidate is ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT